Julie Fitzgerald to Neoplasm Recurrence, Local
This is a "connection" page, showing publications Julie Fitzgerald has written about Neoplasm Recurrence, Local.
Connection Strength
0.030
-
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial. J Clin Oncol. 2021 03 10; 39(8):920-930.
Score: 0.030